Patent: 8,153,591
✉ Email this page to a colleague
Summary for Patent: 8,153,591
Title: | Protein biomaterials and biocoacervates and methods of making and using thereof |
Abstract: | The present invention relates to protein biocoacervates and biomaterials and the methods of making and using protein biocoacervates and biomaterials. More specifically the present invention relates to protein biocoacervates and biomaterials that may be utilized for various medical applications including, but not limited to, drug delivery devices for the controlled release of pharmacologically active agents, coated medical devices (e.g. stents, valves . . . ), vessels, tubular grafts, vascular grafts, wound healing devices including protein suture biomaterials and biomeshes, dental plugs and implants, skin/bone/tissue grafts, tissue fillers, protein biomaterial adhesion prevention barriers, cell scaffolding and other biocompatible biocoacervate or biomaterial devices. |
Inventor(s): | Masters; David B. (Minneapolis, MN), Berg; Eric P. (Plymouth, MN) |
Assignee: | Gel-Del Technologies, Inc. (St. Paul, MN) |
Application Number: | 10/929,117 |
Patent Claims: | see list of patent claims |
Details for Patent 8,153,591
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Bayer Healthcare Pharmaceuticals Inc. | TRASYLOL | aprotinin | Injection | 020304 | 12/29/1993 | ⤷ Try a Trial | 2040-03-31 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |